Functional and Value-Added Dairy Products and Blood Glucose Control

NCT ID: NCT05400694

Last Updated: 2023-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-01

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Milk proteins possess multiple biological activities including their effect on blood glucose control, satiety and energy intake. The design of functional food products with added milk protein fractions has many challenges related to their inferior sensory properties. Chocolate milk presents the universal vehicle for added milk protein fractions that might partially mask their sensory characteristics. However, commercially produced chocolate milk has a significant amount of added sugar. This project will investigate the properties of a value-added dairy product (chocolate milk with reduced sugar content) enriched with individual milk protein fractions on characteristics of blood glucose control, satiety and energy intake in young healthy adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Glucose, High Metabolic Disease Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Treatments are blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chocolate milk

Chocolate milk with reduced added sugar

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with reduced sugar content

Chocolate milk with whey protein

Chocolate milk with reduced added sugar and added whey protein

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with reduced sugar content

Chocolate milk with casein

Chocolate milk with reduced added sugar and added casein

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with reduced sugar content

Chocolate milk with alpha-lactalbumin

Chocolate milk with reduced added sugar and added alpha-lactalbumin

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with reduced sugar content

Chocolate milk with glycomacropeptide

Chocolate milk with reduced added sugar and added glycomacropeptide

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with reduced sugar content

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Food

Dairy products with reduced sugar content

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 19-35 y males and females, non-smokers

Exclusion Criteria

* having any diseases, irregular menses in females, smoking (all types), taking medications known to influence blood glucose control, skipping breakfast, and having emotional, or learning problems that would affect their ability to participate in the study as required. Individuals with known food allergies and lactose intolerance will be also excluded.
Minimum Eligible Age

19 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role collaborator

Mount Saint Vincent University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bohdan Luhovyy

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bohdan Luhovyy, PhD

Role: PRINCIPAL_INVESTIGATOR

Mount Saint Vincent University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Saint Vincent University

Halifax, Nova Scotia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-202-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.